Autoimmune Disorders clinical trials

Explore recruiting autoimmune disorders clinical trials.

Recruiting autoimmune disorders studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autoimmune Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: a randomized controlled multicenter trial

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Spain, Netherlands, France, Germany, Austria, Belgium +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A clinical trial to evaluate the long-term safety and durability of efficacy of BI 3720931, an inhaled lentiviral vector gene therapy, after single dose administration in a previous clinical trial in people with cystic fibrosis rolled-over from a previous clinical trial with BI 3720931 (LenticlairTM-ON).

Spain, France, Italy, Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study with an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis

Italy, Belgium, France, Spain, Denmark, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-Term Follow-up of Subjects With Transfusion-Dependant β-Thalassemia Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector

Germany, France, Italy, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

A FIRST-IN-HUMAN PHASE I TRIAL OF OX118 IN HEALTHY VOLUNTEERS

Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Autoimmune Disorders trials by city

Autoimmune Disorders in Toronto Autoimmune Disorders in Vancouver Autoimmune Disorders in Montreal Autoimmune Disorders in Calgary Autoimmune Disorders in Edmonton Autoimmune Disorders in Ottawa Autoimmune Disorders in Winnipeg Autoimmune Disorders in Quebec City Autoimmune Disorders in Hamilton Autoimmune Disorders in Kitchener Autoimmune Disorders in London Autoimmune Disorders in Halifax Autoimmune Disorders in New York Autoimmune Disorders in Los Angeles Autoimmune Disorders in Chicago Autoimmune Disorders in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease